Author:
Hoellman D.B.,Kelly L.M.,Jacobs M.R.,Appelbaum P.C.
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference19 articles.
1. Characterization of β-lactamases from non-B. fragilis group Bacteroides spp. belonging to seven species and their role in β-lactam resistance;Appelbaum;Antimicrob Agents Chemother,1990
2. β-Lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides and 129 fusobacteria from 28 US centers;Appelbaum;Antimicrob Agents Chemother,1990
3. Susceptibilities of 394 B. fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents;Appelbaum;Antimicrob Agents Chemother,1991
4. Susceptibility of 539 gram-positive and -negative anaerobes to new agents, including RP 59500, biapenem, trospectomycin and piperacillin/tazobactam;Appelbaum;J Antimicrob Chemother,1993
5. Characterization of a β-lactamase from Clostridium clostridioforme;Appelbaum;J Antimicrob Chemother,1994
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Other β-Lactam Antibiotics;Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases;2015
2. β‐Lactam Antibiotics;Burger's Medicinal Chemistry and Drug Discovery;2010-09-15
3. Concentrations of piperacillin–tazobactam in human jaw and hip bone;Journal of Cranio-Maxillofacial Surgery;2008-12
4. Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination;Expert Review of Anti-infective Therapy;2007-06
5. Antimicrobial and healing activity of kefir and kefiran extract;International Journal of Antimicrobial Agents;2005-05